Myles Minter
Stock Analyst at William Blair
(1.70)
# 1,271
Out of 4,479 analysts
16
Total ratings
50%
Success rate
-6.72%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPHM Reneo Pharmaceuticals | Initiates: Outperform | n/a | $1.51 | - | 1 | Nov 15, 2023 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $9.80 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $21.48 | +230.54% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $117.07 | - | 1 | Jul 24, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiates: Outperform | n/a | $473.78 | - | 1 | May 30, 2023 | |
| PRAX Praxis Precision Medicines | Downgrades: Market Perform | n/a | $39.27 | - | 2 | Mar 6, 2023 | |
| ARGX argenx SE | Initiates: Outperform | n/a | $435.49 | - | 1 | Dec 7, 2022 | |
| LRMR Larimar Therapeutics | Upgrades: Outperform | n/a | $7.71 | - | 3 | Sep 19, 2022 | |
| ALNY Alnylam Pharmaceuticals | Initiates: Outperform | n/a | $247.61 | - | 1 | Jun 7, 2022 | |
| IONS Ionis Pharmaceuticals | Upgrades: Outperform | n/a | $45.14 | - | 1 | Dec 14, 2021 | |
| ALEC Alector | Initiates: Outperform | n/a | $4.34 | - | 1 | Sep 27, 2021 | |
| TBIO Telesis Bio | Downgrades: Market Perform | n/a | $3.74 | - | 1 | Aug 3, 2021 | |
| NBIX Neurocrine Biosciences | Initiates: Outperform | n/a | $137.49 | - | 1 | Feb 24, 2020 |
Reneo Pharmaceuticals
Nov 15, 2023
Initiates: Outperform
Price Target: n/a
Current: $1.51
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $9.80
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $21.48
Upside: +230.54%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $117.07
Upside: -
Vertex Pharmaceuticals
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $473.78
Upside: -
Praxis Precision Medicines
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $39.27
Upside: -
argenx SE
Dec 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $435.49
Upside: -
Larimar Therapeutics
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $7.71
Upside: -
Alnylam Pharmaceuticals
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $247.61
Upside: -
Ionis Pharmaceuticals
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $45.14
Upside: -
Alector
Sep 27, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.34
Upside: -
Telesis Bio
Aug 3, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $3.74
Upside: -
Neurocrine Biosciences
Feb 24, 2020
Initiates: Outperform
Price Target: n/a
Current: $137.49
Upside: -